Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Midwestern University
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Eligible patients are male or female adults ≥18 years of age with an expected hospital stay of at least 48 hours, who have end-stage renal disease and been receiving intermittent hemodialysis for at least 90 days.
Eligible patients will additionally have either central or peripheral intravenous access, and will already be prescribed ceftazidime per their primary providers.
Written informed consent in a form approved by Northwestern Memorial Hospital, Northwestern University Institutional Review Board, and Midwestern University Institutional Review Board will be completed by the patient prior to enrollment.
You may not be if
Patients that only receive one dose of ceftazidime in total
Patients with potentially altered pharmacokinetic parameters (pregnant patients, burn patients, and those that are morbidly obese (BMI ≥ 40 kg/m2).
